Jennifer Tousignant - Mar 3, 2025 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Chief Legal Officer
Signature
/s/Jennifer Tousignant
Stock symbol
VRDN
Transactions as of
Mar 3, 2025
Transactions value $
$0
Form type
4
Date filed
3/4/2025, 09:17 PM
Previous filing
Feb 14, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +124K $0.00 124K Mar 3, 2025 Common Stock 124K $14.41 Direct F1
transaction VRDN Restricted Stock Units Award $0 +20.7K $0.00 20.7K Mar 3, 2025 Common Stock 20.7K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in 48 equal monthly installments following the date of the grant, subject to the Reporting Person's continued service to Issuer through each vesting date. The date of the grant is March 3, 2025.
F2 Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of the Issuer.
F3 The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 3, 2025, subject to the Reporting Person's continued service to Issuer through each vesting date.